SCORPION THERAPEUTICS, INC.
Profile
Company Names
SCORPION THERAPEUTICS, INC.
Addresses
1 WINTHROP SQUARE, SUITE 400, BOSTON, MA 02110
888 BOYLSTON STREET, SUITE 1111, BOSTON, MA 02199
Phone Numbers
781-288-5760
212-841-1015
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2020
State Incorporated:
DELAWARE
Total Amount Raised:
$297,375,413.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-07-01
$125,694,186.00
$150,000,002.00
$24,305,816.00
Equity
2
2020-11-20
$146,999,977.00
INDEFINITE
INDEFINITE
Equity
1
2020-04-23
$24,681,250.00
INDEFINITE
INDEFINITE
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY
ALBERS
DIRECTOR
SHELLEY
CHU
DIRECTOR
KALIDEX PHARMACEUTICALS, INC.
| ABINGWORTH BIOVENTURES VII LP
| VENATORX PHARMACEUTICALS, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| SCORPION THERAPEUTICS, INC.
| ENLAZA THERAPEUTICS, INC.
| ABATA THERAPEUTICS, INC.
| PROTEGO BIOPHARMA
| TRIANA BIOMEDICINES, INC.
| SEISMIC THERAPEUTIC, INC.
| ANTARES THERAPEUTICS, INC.
| PROTEGO BIOPHARMA, INC.
| ODYSSEY THERAPEUTICS, INC.
KEITH
FLAHERTY
DIRECTOR
JEAN-FRANCOIS
FORMELA
DIRECTOR
ARCA BIOPHARMA, INC.
| RESOLVYX PHARMACEUTICALS, INC.
| HORIZON PHARMA, INC.
| ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| COSTIM PHARMACEUTICALS INC.
| CALORICS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| INTELLIA THERAPEUTICS, INC.
| IFM THERAPEUTICS, INC.
| SPERO THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| IFM TRE, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| TRANSLATE BIO, INC.
| KORRO BIO, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| ATLAS VENTURE FUND XII, L.P.
| SCORPION THERAPEUTICS, INC.
| SPERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| AMAGMA, INC.
| IKENA ONCOLOGY, INC.
| ANTARES THERAPEUTICS, INC.
ADAM
FRIEDMAN
EXECUTIVE OFFICER, DIRECTOR
GARY
GLICK
EXECUTIVE OFFICER, DIRECTOR
ARJUN
GOYAL
DIRECTOR
OLEG
NODELMAN
DIRECTOR
BIOTECHNOLOGY VALUE FUND II LP
| BIOTECHNOLOGY VALUE FUND L P
| ECOR1 CAPITAL FUND, L.P.
| ECOR1 CAPITAL FUND QUALIFIED, L.P.
| ECOR1 VENTURE OPPORTUNITY FUND, LP
| ECOR1 VENTURE OPPORTUNITY OFFSHORE FUND, L.P.
| RECODE THERAPEUTICS, INC.
| SCORPION THERAPEUTICS, INC.
| AKTIS ONCOLOGY, INC.
| EPIKAST INC.
BRIAN
PIPER
EXECUTIVE OFFICER
OTELLO
STAMPACCHIA
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-07-01
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

